These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18271962)

  • 1. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study.
    Dumeaux V; Børresen-Dale AL; Frantzen JO; Kumle M; Kristensen VN; Lund E
    Breast Cancer Res; 2008; 10(1):R13. PubMed ID: 18271962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new statistical method for curve group analysis of longitudinal gene expression data illustrated for breast cancer in the NOWAC postgenome cohort as a proof of principle.
    Lund E; Holden L; Bøvelstad H; Plancade S; Mode N; Günther CC; Nuel G; Thalabard JC; Holden M
    BMC Med Res Methodol; 2016 Mar; 16():28. PubMed ID: 26944545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
    Delgado AB; Tylden ES; Lukic M; Moi L; Busund LR; Lund E; Olsen KS
    PLoS One; 2023; 18(2):e0281218. PubMed ID: 36745618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
    Olsen KS; Holden M; Thalabard JC; Rasmussen Busund LT; Lund E; Holden L
    PLoS One; 2021; 16(3):e0246650. PubMed ID: 33684121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
    Lund E; Mode N; Waaseth M; Thalabard JC
    BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.
    Jareid M; Snapkov I; Holden M; Busund LR; Lund E; Nøst TH
    PLoS One; 2021; 16(8):e0256442. PubMed ID: 34449791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression in blood reflects smoking exposure among cancer-free women in the Norwegian Women and Cancer (NOWAC) postgenome cohort.
    Baiju N; Sandanger TM; Sætrom P; Nøst TH
    Sci Rep; 2021 Jan; 11(1):680. PubMed ID: 33436844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K; Alsaker E; Eggen AE; Lund E
    Int J Cancer; 2004 Oct; 112(1):130-4. PubMed ID: 15305384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering normal blood gene expression variation--The NOWAC postgenome study.
    Dumeaux V; Olsen KS; Nuel G; Paulssen RH; Børresen-Dale AL; Lund E
    PLoS Genet; 2010 Mar; 6(3):e1000873. PubMed ID: 20300640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
    Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;
    BMC Cancer; 2017 Nov; 17(1):785. PubMed ID: 29166878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
    Busund M; Bugge NS; Braaten T; Waaseth M; Rylander C; Lund E
    Int J Cancer; 2018 Jun; 142(11):2293-2302. PubMed ID: 29349773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and blood gene expression profiles: the Norwegian Women and Cancer (NOWAC) Post-genome cohort.
    Olsen KS; Lukic M; Borch KB
    BMC Res Notes; 2020 Jun; 13(1):283. PubMed ID: 32527328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study.
    Lukic M; Licaj I; Lund E; Skeie G; Weiderpass E; Braaten T
    Eur J Epidemiol; 2016 Sep; 31(9):905-16. PubMed ID: 27010635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients.
    Lund E; Nakamura A; Snapkov I; Thalabard JC; Olsen KS; Holden L; Holden M
    Clin Epidemiol; 2018; 10():931-940. PubMed ID: 30123005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary patterns and lifestyle factors in the Norwegian EPIC cohort: the Norwegian Women and Cancer (NOWAC) study.
    Engeset D; Alsaker E; Ciampi A; Lund E
    Eur J Clin Nutr; 2005 May; 59(5):675-84. PubMed ID: 15785773
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.